anti-MUC1 CAR-pNK cells: Clinical Trials

1 trial of anti-MUC1 CAR-pNK cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow anti-MUC1 CAR-pNK cells: new trials by email Literature Review of anti-MUC1 CAR-pNK cells trials Research Report on anti-MUC1 CAR-pNK cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
anti-MUC1 CAR-pNK cells - Hepatocellular Carcinoma, Non-small Cell Lung Cancer
Phase 1 / Phase 2UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102016-07-012016-12-06

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Stomach Neoplasms (1)

Sponsors

PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1)

Countries

China (1)

Top investigators

Lin Yang, Ph.D. (1)

Results publications

PMID 28054442, PMID 41121171